These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 38601497)

  • 21. Incidence and risk factors for acquired colonization and infection due to extended-spectrum beta-lactamase-producing Gram-negative bacilli: a retrospective analysis in three ICUs with low multidrug resistance rate.
    Massart N; Camus C; Benezit F; Moriconi M; Fillatre P; Le Tulzo Y
    Eur J Clin Microbiol Infect Dis; 2020 May; 39(5):889-895. PubMed ID: 31898797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High Prevalence of Antimicrobial Resistance Among Gram-Negative Isolated Bacilli in Intensive Care Units at a Tertiary-Care Hospital in Yucatán Mexico.
    Uc-Cachón AH; Gracida-Osorno C; Luna-Chi IG; Jiménez-Guillermo JG; Molina-Salinas GM
    Medicina (Kaunas); 2019 Sep; 55(9):. PubMed ID: 31540314
    [No Abstract]   [Full Text] [Related]  

  • 23. Phenotypic and genotypic detection of resistance mechanisms in carbapenem-resistant gram-negative bacteria isolated from Egyptian ICU patients with first emergence of NDM-1 producing
    Fawzy RH; Gad GFM; Mohamed HA
    Iran J Microbiol; 2022 Dec; 14(6):832-840. PubMed ID: 36721446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Global Threat of Carbapenem-Resistant Gram-Negative Bacteria.
    Jean SS; Harnod D; Hsueh PR
    Front Cell Infect Microbiol; 2022; 12():823684. PubMed ID: 35372099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection and characterization of carbapenem resistant Gram-negative bacilli isolates recovered from hospitalized patients at Soba University Hospital, Sudan.
    Elbadawi HS; Elhag KM; Mahgoub E; Altayb HN; Ntoumi F; Elton L; McHugh TD; Tembo J; Ippolito G; Osman AY; Zumla A; Hamid MMA
    BMC Microbiol; 2021 May; 21(1):136. PubMed ID: 33947325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High antimicrobial resistant rates among Gram-negative pathogens in intensive care units. A retrospective study at a tertiary care hospital in Southwest Saudi Arabia.
    Ibrahim ME
    Saudi Med J; 2018 Oct; 39(10):1035-1043. PubMed ID: 30284588
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and mortality of ceftazidime/avibactam-based regimens in carbapenem-resistant Gram-negative bacteria infections: A retrospective multicenter observational study.
    Zhuang HH; Chen Y; Hu Q; Long WM; Wu XL; Wang Q; Xu TT; Qu Q; Liu YP; Xiao YW; Qu J
    J Infect Public Health; 2023 Jun; 16(6):938-947. PubMed ID: 37087853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for nosocomial rectal colonisation with carbapenem-resistant Gram-negative bacilli in children with haematological malignancies: a case-control study.
    Fang C; Zhou Z; Zhou M; Li J
    Ann Clin Microbiol Antimicrob; 2023 Aug; 22(1):66. PubMed ID: 37537568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination therapy for carbapenem-resistant Gram-negative bacteria.
    Zavascki AP; Bulitta JB; Landersdorfer CB
    Expert Rev Anti Infect Ther; 2013 Dec; 11(12):1333-53. PubMed ID: 24191943
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early prediction of carbapenem-resistant Gram-negative bacterial carriage in intensive care units using machine learning.
    Liang Q; Zhao Q; Xu X; Zhou Y; Huang M
    J Glob Antimicrob Resist; 2022 Jun; 29():225-231. PubMed ID: 35351674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
    Wang J; Shah BK; Zhao J; Xiong J; Wang C; Xie S
    BMC Infect Dis; 2023 May; 23(1):351. PubMed ID: 37231342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients.
    Armand-Lefèvre L; Angebault C; Barbier F; Hamelet E; Defrance G; Ruppé E; Bronchard R; Lepeule R; Lucet JC; El Mniai A; Wolff M; Montravers P; Plésiat P; Andremont A
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1488-95. PubMed ID: 23318796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All-cause mortality rates in adults with carbapenem-resistant Gram-negative bacterial infections: a comprehensive review of pathogen-focused, prospective, randomized, interventional clinical studies.
    Lodise TP; Bassetti M; Ferrer R; Naas T; Niki Y; Paterson DL; Zeitlinger M; Echols R
    Expert Rev Anti Infect Ther; 2022 May; 20(5):707-719. PubMed ID: 34937518
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of combination therapy in the treatment of severe infections caused by carbapenem resistant gram-negatives: a systematic review of clinical studies.
    Savoldi A; Carrara E; Piddock LJV; Franceschi F; Ellis S; Chiamenti M; Bragantini D; Righi E; Tacconelli E
    BMC Infect Dis; 2021 Jun; 21(1):545. PubMed ID: 34107899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiology, Outcomes and Resource Utilisation in Patients with Carbapenem Non-susceptible Gram-Negative Bacteria in the UK: A Retrospective, Observational Study (CARBAR UK).
    Goldenberg SD; Dodgson AR; Barlow G; Parcell BJ; Jones L; Albur M; Wilson APR; Enoch DA; Marek A; Micallef C; Manissero D; Longshaw C; Lopes S; Gill K
    Adv Ther; 2022 Aug; 39(8):3602-3615. PubMed ID: 35701725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rapid Antibiotic Combination Testing for Carbapenem-Resistant Gram-Negative Bacteria within Six Hours Using ATP Bioluminescence.
    Cai Y; Seah CL; Leck H; Lim TP; Teo JQ; Lee W; Tan TT; Koh TH; Ee PLR; Kwa AL
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29967021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do specific antimicrobial stewardship interventions have an impact on carbapenem resistance in Gram-negative bacilli? A multicentre quasi-experimental ecological study: time-trend analysis and characterization of carbapenemases.
    Álvarez-Marín R; López-Cerero L; Guerrero-Sánchez F; Palop-Borras B; Rojo-Martín MD; Ruiz-Sancho A; Herrero-Rodríguez C; García MV; Lazo-Torres AM; López I; Martín-Hita L; Nuño-Álvarez E; Sánchez-Yebra W; Galán-Sánchez F; Reguera-Iglesias JM; Lepe JA; Peñalva G; Pascual Á; Cisneros JM;
    J Antimicrob Chemother; 2021 Jun; 76(7):1928-1936. PubMed ID: 33769481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotics with activity against intestinal anaerobes and the hazard of acquired colonization with ceftriaxone-resistant Gram-negative pathogens in ICU patients: a propensity score-based analysis.
    Boutrot M; Azougagh K; Guinard J; Boulain T; Barbier F
    J Antimicrob Chemother; 2019 Oct; 74(10):3095-3103. PubMed ID: 31289826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidrug-Resistant Gram-Negative Bacilli: A Retrospective Study of Trends in a Tertiary Healthcare Unit.
    Muntean D; Horhat FG; Bădițoiu L; Dumitrașcu V; Bagiu IC; Horhat DI; Coșniță DA; Krasta A; Dugăeşescu D; Licker M
    Medicina (Kaunas); 2018 Nov; 54(6):. PubMed ID: 30486311
    [No Abstract]   [Full Text] [Related]  

  • 40. Carbapenem-resistant Gram-negative bacteria associated with catheter-related bloodstream infections in three intensive care units in Egypt.
    Abdulall AK; Tawfick MM; El Manakhly AR; El Kholy A
    Eur J Clin Microbiol Infect Dis; 2018 Sep; 37(9):1647-1652. PubMed ID: 29936619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.